tiprankstipranks

Nadav Kidron Insider Profile

11 Followers
Nadav Kidron, President & CEO, Director at Oramed Pharm, holds 1.91M shares in Oramed Pharm (Ticker: ORMP).
tipranks
Nadav Kidron

Nadav Kidron
Oramed Pharm (ORMP)
President & CEO, Director

Ranked #7,814 out of 98,624 Corporate Insiders

Profitable Transactions

86%
6 out of 7 Profitable Transactions

Average Return

+29.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$4M
100.00%
A breakdown of Nadav Kidron's holdings

Insider Roles

Oramed Pharm
(ORMP)
President & CEO, Director
Roles that Nadav Kidron holds in companies

Most Profitable Insider Trade

Stock:
Oramed Pharm
(ORMP)
Rating:Informative Buy
Date:Mar 20, 2015 - Mar 20, 2016
Return:+56.90%
The most profitable trade made by Nadav Kidron

Nadav Kidron's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Oramed Pharm
Jan 08, 2024
President & CEO, Director
Uninformative Buy
$4.48M
Success Rate for
ORMP
6 out of 7 profitable transactions on
ORMP
86%
Average Return for
ORMP
Average return per transaction on
ORMP
+29.27%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Feb 25, 2015
Uninformative Buy
$0.00
-
$0.00
May 12, 2016
Informative Buy
$6.95K
-
$6.95
+21.90%
May 31, 2023
Uninformative Buy
$0.00
-
$0.00
Jan 08, 2024
Uninformative Buy
$0.00
-
$0.00
Oct 28, 2022
Uninformative Sell
$0.00
-
$0.00
List of latest transactions for each holding click on a transaction to see Nadav Kidron's performance on stock

Nadav Kidron insider profile FAQ

What is the percentage of profitable transactions made by Nadav Kidron?
The percentage of profitable transactions made by Nadav Kidron is 86%.
    What is the average return per transaction made by Nadav Kidron?
    The average return per transaction made by Nadav Kidron is 29.20%.
      What stocks does Nadav Kidron hold?
      Nadav Kidron holds: ORMP stocks.
        What was Nadav Kidron’s latest transaction?
        Nadav Kidron latest transaction was an Uninformative Buy of ―.
          What was Nadav Kidron's most profitable transaction?
          Nadav Kidron’s most profitable transaction was an Informative Buy of ORMP stock on March 20, 2015. The return on the trade was 56.90%.
            What is Nadav Kidron's role in Oramed Pharm?
            Nadav Kidron's role in Oramed Pharm is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.